“…A majority of the papers reviewed in this section utilize either E. coli , [ 157 , 160 , 161 , 170 , 190 ] Staphylococcus aureus , [ 184 , 192 ] or both [ 153 , 154 , 155 , 156 , 158 , 162 , 165 , 166 , 168 , 169 , 171 , 173 , 174 , 176 , 183 , 184 ] to test IL/formulation bactericidal efficacy. The two bacterial strains are extremely clinically relevant, as these are both common bacterial infections in humans, and they E. coli and S. aureus represent two general categories of bacteria, Gram‐negative and Gram‐positive, respectively.…”